Home/Filings/4/0001600132-19-000084
4//SEC Filing

Tenenbaum Fabian 4

Accession 0001600132-19-000084

CIK 0001600132other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 11:14 AM ET

Size

4.5 KB

Accession

0001600132-19-000084

Insider Transaction Report

Form 4
Period: 2019-05-21
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2019-05-21$0.59/sh+5,000$2,975484,282 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001641300

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 11:14 AM ET
Size
4.5 KB